{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "EGFR",
        "Protein_Change": {
          "ref": "L",
          "alt": "R",
          "position": "858"
        },
        "variant_string_id": "EGFR L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism.",
          "extracted_paper_info": "The pathogenesis of **lung cancer** is well-established.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that the functional assay aims to elucidate the mechanism of lung cancer, which is a known disease with a defined molecular basis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field.",
          "extracted_paper_info": "Enzymatic activity assays are widely employed in the field to evaluate EGFR mutations' impact on kinase activity.",
          "judgment": "Yes",
          "reasoning": "The paper mentions the use of a kinase activity assay, which is a well-accepted class of assay for assessing EGFR variants in relation to lung cancer pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Kinase assays were performed in triplicate using wild-type EGFR control and known pathogenic mutant controls.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the use of both wild-type and pathogenic mutant controls and mentions triplicate experiments, indicating adherence to basic standards.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Several known pathogenic and benign EGFR variants were tested as controls.",
          "judgment": "Yes",
          "reasoning": "The paper mentions the use of both known pathogenic and benign variant controls, which helps to validate the assay's specificity.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analyses revealed a significant increase in kinase activity for the L858R variant compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The paper provides statistical evidence (p-value, effect size) that allows for the estimation of OddsPath.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "The calculated OddsPath for the L858R variant was 30.5, indicating a high likelihood of pathogenicity.",
          "judgment": "Yes",
          "reasoning": "The OddsPath calculated in the paper is well above the threshold for PS3_very_strong.",
          "next_step_or_outcome": "Final Outcome"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The EGFR L858R variant was assessed as PS3_very_strong based on clear disease mechanism definition, the use of an applicable assay class, adequate basic controls and replicates, variant-specific controls, and robust statistical analyses that yielded a high OddsPath value."
    },
    {
      "variant_id": {
        "Gene": "CFTR",
        "Protein_Change": {
          "ref": "R",
          "alt": "H",
          "position": "117"
        },
        "variant_string_id": "CFTR R117H"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism.",
          "extracted_paper_info": "The pathogenesis of **cystic fibrosis** is well-established.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that the functional assay aims to elucidate the mechanism of cystic fibrosis, which is a known disease with a defined molecular basis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field.",
          "extracted_paper_info": "Gene expression assays are widely employed in the field to evaluate CFTR mutations' impact on gene expression.",
          "judgment": "Yes",
          "reasoning": "The paper mentions the use of a gene expression assay, which is a well-accepted class of assay for assessing CFTR variants in relation to cystic fibrosis pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "Gene expression assays were performed in triplicate using wild-type CFTR control and known pathogenic mutant controls.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the use of both wild-type and pathogenic mutant controls and mentions triplicate experiments, indicating adherence to basic standards.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Several known pathogenic and benign CFTR variants were tested as controls.",
          "judgment": "Yes",
          "reasoning": "The paper mentions the use of both known pathogenic and benign variant controls, which helps to validate the assay's specificity.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "Statistical analyses revealed no significant difference in gene expression for the R117H variant compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The paper provides statistical evidence (p-value, effect size) that allows for the estimation of OddsPath.",
          "next_step_or_outcome": "Proceed to Step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "The calculated OddsPath for the R117H variant was 0.15, indicating a low likelihood of pathogenicity.",
          "judgment": "Yes",
          "reasoning": "The OddsPath calculated in the paper is well below the threshold for BS3_very_strong.",
          "next_step_or_outcome": "Final Outcome"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_very_strong"
      },
      "overall_conclusion": "The CFTR R117H variant was assessed as BS3_very_strong based on clear disease mechanism definition, the use of an applicable assay class, adequate basic controls and replicates, variant-specific controls, and robust statistical analyses that yielded a low OddsPath value."
    }
  ]
}